Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Aging Health. 2018 Aug 30;31(2):322–342. doi: 10.1177/0898264318795567

Table 4.

Cox Proportional Hazards—Additive Effects for Sleep Disturbance × e4 Carrier Status: Outcome: Probable AD.

Sleep disturbance ×
e4 carrier(unadjusted)
Sleep disturbance ×
e4 carrier adjusteda
with demographics
Sleep disturbance × e4
carrier adjustedb with
demographics and AD medication use
Hazard ratio (95% Cl) Hazard ratio (95% Cl) Hazard ratio (95% Cl)
Sleep disturbance ×
e4 carrier
3.02 [1.77,5.13]*** 4.83 [2.90, 8.03]*** 4.38 [2.54, 7.55]***
Use of sleep
medication (general)
3.57 [1.26, 10.1]** 4.61 [1.76, 12.1]*** 2.40 [0.49, 11.7]
Did not use sleep
medication
2.80 [1.51, 5.20]*** 4.80 [2.58, 8.92]*** 4.70 [2.50, 8.85]***
Trazodone use 1.64 [0.41, 6.65] 1.64 [0.60,4.46] 0.79 [0.15,4.11]
No trazodone use 3.10 [1.75, 5.50]*** 5.11 [2.88,9.05]*** 5.03 [2.81,9.03]***
Zolpidem use 6.43 [1.39,29.7]** 7.82 [1.56, 39.1]** 12.0 [2.28,63.4]***
No zolpidem use 2.81 [1.59,4.95]*** 4.54 [2.64, 7.78]*** 4.16 [2.34,7.39]***

Note. AD = Alzheimer’s disease; CI = confidence interval.

a

Adjusted for sex, age, education, race, and Hispanic origin.

b

Adjusted for sex, age, education, race, Hispanic origin, and AD medication use. *p < .1.

**

p < .05.

***

p < .01.